JP2007535495A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007535495A5 JP2007535495A5 JP2007500249A JP2007500249A JP2007535495A5 JP 2007535495 A5 JP2007535495 A5 JP 2007535495A5 JP 2007500249 A JP2007500249 A JP 2007500249A JP 2007500249 A JP2007500249 A JP 2007500249A JP 2007535495 A5 JP2007535495 A5 JP 2007535495A5
- Authority
- JP
- Japan
- Prior art keywords
- albumin
- filter
- nanofiltration
- virus
- aqueous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000009027 Albumins Human genes 0.000 description 8
- 108010088751 Albumins Proteins 0.000 description 8
- 241000700605 Viruses Species 0.000 description 3
- 238000001728 nano-filtration Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000029797 Prion Human genes 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0402001A FR2866890B1 (fr) | 2004-02-27 | 2004-02-27 | Procede de purification d'albumine comprenant une etape de nanofiltration, solution et composition a usage therapeutique la contenant |
| FR0402001 | 2004-02-27 | ||
| PCT/FR2005/000416 WO2005090402A1 (fr) | 2004-02-27 | 2005-02-23 | Procede de purificaton d’albumine comprenant une etape de nanofiltration, solution et composition a usage therapeutique la contenant |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011280288A Division JP2012102115A (ja) | 2004-02-27 | 2011-12-21 | ナノ濾過工程を含むアルブミン精製方法、それを含有する治療用途のための溶液及び組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007535495A JP2007535495A (ja) | 2007-12-06 |
| JP2007535495A5 true JP2007535495A5 (enExample) | 2011-05-12 |
| JP4979571B2 JP4979571B2 (ja) | 2012-07-18 |
Family
ID=34834103
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007500249A Expired - Fee Related JP4979571B2 (ja) | 2004-02-27 | 2005-02-23 | ナノ濾過工程を含むアルブミン精製方法、それを含有する治療用途のための溶液及び組成物 |
| JP2011280288A Pending JP2012102115A (ja) | 2004-02-27 | 2011-12-21 | ナノ濾過工程を含むアルブミン精製方法、それを含有する治療用途のための溶液及び組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011280288A Pending JP2012102115A (ja) | 2004-02-27 | 2011-12-21 | ナノ濾過工程を含むアルブミン精製方法、それを含有する治療用途のための溶液及び組成物 |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US20070161122A1 (enExample) |
| EP (1) | EP1718673B1 (enExample) |
| JP (2) | JP4979571B2 (enExample) |
| AT (1) | ATE373014T1 (enExample) |
| AU (1) | AU2005223418B2 (enExample) |
| BR (1) | BRPI0507886A (enExample) |
| CA (1) | CA2557174C (enExample) |
| CY (1) | CY1107082T1 (enExample) |
| DE (1) | DE602005002461T2 (enExample) |
| DK (1) | DK1718673T3 (enExample) |
| ES (1) | ES2294696T3 (enExample) |
| FR (1) | FR2866890B1 (enExample) |
| IL (1) | IL177286A (enExample) |
| PL (1) | PL1718673T3 (enExample) |
| PT (1) | PT1718673E (enExample) |
| WO (1) | WO2005090402A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2866890B1 (fr) * | 2004-02-27 | 2008-04-04 | Lab Francais Du Fractionnement | Procede de purification d'albumine comprenant une etape de nanofiltration, solution et composition a usage therapeutique la contenant |
| FR2887883B1 (fr) | 2005-06-29 | 2007-08-31 | Lab Francais Du Fractionnement | Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines |
| FR2894831B1 (fr) | 2005-12-16 | 2008-02-15 | Lab Francais Du Fractionnement | Colle biologique exempte de thrombine et son utilisation comme medicament. |
| ES2294976B1 (es) * | 2007-11-12 | 2008-12-16 | Grifols, S.A. | "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion". |
| JP6189751B2 (ja) | 2010-12-30 | 2017-08-30 | ラボラトワール フランセ デュ フラクショヌマン エ デ ビオテクノロジーＬａｂｏｒａｔｏｉｒｅ Ｆｒａｎｃａｉｓ ｄｕ Ｆｒａｃｔｉｏｎｎｅｍｅｎｔ ｅｔ ｄｅｓ Ｂｉｏｔｅｃｈｎｏｌｏｇｉｅｓ | 病原体不活性化剤としてのグリコール |
| FR3004451B1 (fr) * | 2013-04-11 | 2015-12-11 | Lab Francais Du Fractionnement | Procede de preparation d'une solution de proteine c viralement securisee par une double etape de nanofiltration |
| US20180028593A1 (en) * | 2014-03-21 | 2018-02-01 | Boreal Invest | Terminal nanofiltration of solubilized protein compositions for removal of immunogenic aggregates |
| FR3040882A1 (fr) * | 2015-09-10 | 2017-03-17 | Lab Francais Du Fractionnement | Composition liquide d'albumine humaine a usage therapeutique |
| AU2021213787B2 (en) * | 2020-01-30 | 2024-02-29 | Fresenius Medical Care Holdings, Inc. | Techniques for modelling and optimizing dialysis toxin displacer compounds |
| US12161777B2 (en) | 2020-07-02 | 2024-12-10 | Davol Inc. | Flowable hemostatic suspension |
| US11739166B2 (en) | 2020-07-02 | 2023-08-29 | Davol Inc. | Reactive polysaccharide-based hemostatic agent |
| JP2024500994A (ja) | 2020-12-28 | 2024-01-10 | デボル，インコーポレイテッド | タンパク質及び多官能化変性ポリエチレングリコール系架橋剤を含む反応性乾燥粉末状止血用材料 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9019919D0 (en) | 1990-09-12 | 1990-10-24 | Delta Biotechnology Ltd | Purification of proteins |
| FR2672604B1 (fr) * | 1991-02-07 | 1995-05-05 | Pasteur Merieux Serums Vacc | Procede pour isoler de l'albumine humaine a partir du surnageant iv, notamment iv-4, ou de la fraction v de cohn ou d'un surnageant ou fraction analogue. |
| US5849874A (en) * | 1991-07-12 | 1998-12-15 | Gist-Brocades, N.V. | Process for the purification of serum albumin |
| US5440018A (en) | 1992-05-20 | 1995-08-08 | The Green Cross Corporation | Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same |
| JPH06279296A (ja) * | 1993-03-25 | 1994-10-04 | Asahi Chem Ind Co Ltd | 血漿分画製剤中から蛋白質会合物の除去方法 |
| SE9500724D0 (sv) * | 1994-06-23 | 1995-02-24 | Pharmacia Ab | Filtrering |
| US6210683B1 (en) * | 1997-09-05 | 2001-04-03 | Merck & Co., Inc. | Stabilizers containing recombinant human serum albumin for live virus vaccines |
| JP4798832B2 (ja) * | 2000-10-24 | 2011-10-19 | 一般財団法人化学及血清療法研究所 | ヒト血清アルブミン多量体の除去方法 |
| DE60121196T2 (de) * | 2000-10-24 | 2007-07-12 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Verfahren zur monomerisierung von humanen serumalbumin-polymeren |
| US6806355B2 (en) * | 2001-08-14 | 2004-10-19 | Statens Serum Institut | Purification process for large scale production of Gc-globulin, the Gc-globulin produced hereby, a use of Gc.globulin and a Gc-globulin medicinal product |
| DE10211632A1 (de) * | 2002-03-15 | 2003-10-09 | Aventis Behring Gmbh | Verfahren zur Abtrennung von Viren aus einer Proteinlösung durch Nanofiltration |
| ES2543978T3 (es) * | 2003-04-09 | 2015-08-26 | The Chemo-Sero-Therapeutic Research Institute | Proceso para la producción de una preparación de albúmina |
| FR2866890B1 (fr) * | 2004-02-27 | 2008-04-04 | Lab Francais Du Fractionnement | Procede de purification d'albumine comprenant une etape de nanofiltration, solution et composition a usage therapeutique la contenant |
-
2004
- 2004-02-27 FR FR0402001A patent/FR2866890B1/fr not_active Expired - Lifetime
-
2005
- 2005-02-23 US US10/589,825 patent/US20070161122A1/en not_active Abandoned
- 2005-02-23 EP EP05731028A patent/EP1718673B1/fr not_active Expired - Lifetime
- 2005-02-23 DK DK05731028T patent/DK1718673T3/da active
- 2005-02-23 BR BRPI0507886-5A patent/BRPI0507886A/pt active Search and Examination
- 2005-02-23 DE DE602005002461T patent/DE602005002461T2/de not_active Expired - Lifetime
- 2005-02-23 AT AT05731028T patent/ATE373014T1/de active
- 2005-02-23 ES ES05731028T patent/ES2294696T3/es not_active Expired - Lifetime
- 2005-02-23 JP JP2007500249A patent/JP4979571B2/ja not_active Expired - Fee Related
- 2005-02-23 CA CA2557174A patent/CA2557174C/fr not_active Expired - Lifetime
- 2005-02-23 PL PL05731028T patent/PL1718673T3/pl unknown
- 2005-02-23 PT PT05731028T patent/PT1718673E/pt unknown
- 2005-02-23 WO PCT/FR2005/000416 patent/WO2005090402A1/fr not_active Ceased
- 2005-02-23 AU AU2005223418A patent/AU2005223418B2/en not_active Ceased
-
2006
- 2006-08-03 IL IL177286A patent/IL177286A/en not_active IP Right Cessation
-
2007
- 2007-12-12 CY CY20071101575T patent/CY1107082T1/el unknown
-
2011
- 2011-12-21 JP JP2011280288A patent/JP2012102115A/ja active Pending
-
2015
- 2015-02-02 US US14/611,460 patent/US9611311B2/en not_active Expired - Lifetime
-
2017
- 2017-02-27 US US15/443,884 patent/US10562957B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007535495A5 (enExample) | ||
| CN103965372B (zh) | 一种壳聚糖-没食子酸接枝共聚物的制备方法 | |
| KR101531479B1 (ko) | 의료용 재료로 사용하기 위한 고농도 콜라겐 제조방법 | |
| US11198742B2 (en) | Process for the purification of hyaluronic acid | |
| JP5755136B2 (ja) | 高濃度モノクローナル抗体溶液中のウイルス除去方法 | |
| JP2015529447A5 (enExample) | ||
| JPH10502074A (ja) | 濾 過 | |
| JP2012102115A (ja) | ナノ濾過工程を含むアルブミン精製方法、それを含有する治療用途のための溶液及び組成物 | |
| JP2016511238A5 (enExample) | ||
| JP6109881B2 (ja) | 固体含有生物抽出物のウイルスおよび微生物含有量を低減する方法 | |
| CA2421681A1 (en) | Method for separating off viruses from a protein solution by means of nanofiltration | |
| JP5908496B2 (ja) | トランスジェニックイネの子実からヒト血清アルブミンを抽出する方法 | |
| JP2012500636A5 (enExample) | ||
| CN102180966B (zh) | 一种规模化生产人α1-抗胰蛋白酶的方法 | |
| Furlán et al. | Assessment of agave fructans as lyoprotectants of bovine plasma proteins concentrated by ultrafiltration | |
| CN100491404C (zh) | 芦荟多糖分级提取方法 | |
| KR101638662B1 (ko) | 히알루론산 및／또는 그의 염의 정제 방법 | |
| PH12023550246A1 (en) | Modified chikungunya viruses and sindbis viruses and uses thereof | |
| CN101503462B (zh) | 一种去除流感病毒原液中内毒素的方法 | |
| JP5522857B2 (ja) | コラーゲンの製造方法 | |
| CN103041380B (zh) | 人抗凝血酶制剂干热处理过程中的稳定剂 | |
| JPH03273002A (ja) | アルギン酸分解物 | |
| RU2341286C1 (ru) | Способ получения кровезаменителя и установка для осуществления способа | |
| CN104804078A (zh) | 人体血清凝血因子ⅷ中的病毒过滤方法 | |
| CN102988989B (zh) | 一种代血浆的膜分离精制提纯方法 |